New Kent spin-out aims to cut cost of producing proteins used in cancer treatments and diagnostics
Peer-Reviewed Publication
Updates every hour. Last Updated: 29-Oct-2026 01:16 ET (29-Oct-2026 05:16 GMT/UTC)
A new University of Kent spin-out has been launched to commercialise biotechnology that could make it cheaper and easier to produce proteins used in cancer treatments, vaccines and diagnostics tests.